Ameritas Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Buy |
4,977
+1,449
| +41% | +$100K | 0.02% | 595 |
|
|
2025
Q1 | $273K | Sell |
3,528
-7,472
| -68% | -$579K | 0.01% | 728 |
|
|
2024
Q4 | $946K | Buy |
11,000
+9,012
| +453% | +$775K | 0.03% | 430 |
|
|
2024
Q3 | $237K | Sell |
1,988
-8,927
| -82% | -$1.06M | 0.01% | 755 |
|
|
2024
Q2 | $1.56M | Sell |
10,915
-307
| -3% | -$43.8K | 0.06% | 306 |
|
|
2024
Q1 | $1.4M | Buy |
11,222
+7,284
| +185% | +$908K | 0.06% | 307 |
|
|
2023
Q4 | $440K | Sell |
3,938
-7,175
| -65% | -$801K | 0.02% | 460 |
|
|
2023
Q3 | $1.1M | Buy |
11,113
+2,493
| +29% | +$246K | 0.05% | 321 |
|
|
2023
Q2 | $677K | Buy |
8,620
+66
| +0.8% | +$5.18K | 0.09% | 235 |
|
|
2023
Q1 | $684K | Buy |
+8,554
| New | +$684K | 0.03% | 401 |
|